Biofrontera Aktiengesellschaft

December 14, 2021, 11:00 AM

Voting results:

Agenda Items Number of Shares with Valid Votes % of Registered Share Capital Votes for % Votes For Votes Against % Votes Against Proposed Decision

2

Resolution concerning the discharge of the members of the Management Board for the 2020 financial year

35,567,873 62.71 16,997,765 47.7897 18,570,108 52.2103 rejected

3

Resolution concerning the discharge of the members of the Supervisory Board for the 2020 financial year

35,206,044 62.07 16,654,145 47.3048 18,551,899 52.6952 rejected

4

Resolution concerning the appointment of the auditors of the separate and consolidated financial statements for the 2021financial year and as auditor for a possible audit review of the condensed interim financial statements and interim management report

35,864,573 63.23 35,067,791 97.7783 796,782 2.2217 approved

5a

Elections to the Supervisory Board, Dr. Heikki Lanckriet, CEO of 4basebio PLC, Cambridge, UK, resident of Cambridge, UK

36,020,251 63.51 32,840,700 91.1728 3,179,551 8.8272 approved

5b

Elections to the Supervisory Board, Dr. Helge Lubenow, CEO of Proteomedix AG, Zurich,

Switzerland, resident of Bad Nauheim, Germany

35,318,964 62.27 33,125,716 93.7901 2,193,248 6.2099 approved

5c

Elections to the Supervisory Board, Prof. Dr. Franca Ruhwedel, Professor of Finance and Accounting at the Rhine-Waal University of Applied Sciences, Kamp-Lintfort, resident of Duisburg

36.021.004 63.51 35.074.176 97.3714 946.828 2.6286 approved
1

Annual General Meeting

Biofrontera Aktiengesellschaft

December 14, 2021, 11:00 AM

Agenda Items Number of Shares with Valid Votes % of Registered Share Capital Votes for % Votes For Votes Against % Votes Against Proposed Decision

5d

Elections to the Supervisory Board, Mr. Karlheinz Schmelig, Managing Director, Creathor Venture Management GmbH, Bad Homburg, resident of Bensheim

35,069,375 61.83 33,830,890 96.4684 1,238,485 3.5316 approved

5e

Elections to the Supervisory Board, Dr. Jörgen Tielmann, Attorney at Law/Partner at Luther Rechtsanwaltsgesellschaft mbH, Cologne, resident of Hamburg

35,076,792 61.84 34,585,948 98.6006 490,844 1.3994 approved

5d

Elections to the Supervisory Board, Mr. Wilhelm K. T. Zours, Member of the Management Board of DELPHI Unternehmensberatung AG, Heidelberg, resident of Heidelberg

36,091,859 63.63 32,609,794 90.3522 3,482,065 9.6478 approved

6

Resolution on the confirmation of remuneration of the Supervisory Board

34,786,334 61.33 33,493,965 96.2848 1,292,369 3.7152 approved

7

Resolution on the approval of the remuneration of the members of the Board of Management

34,743,765 61.26 33,499,225 96.4179 1,244,540 3.5821 approved

8

Resolution on the authorization to create new

Authorized Capital 2021 and on the corresponding amendments to the amendments to the Articles of Association

35,024,789 61.75 18,426,480 52.6098 16,598,309 47.3902 rejected

9

Resolution on (a) the authorization to issue profit-sharing certificates, warrants and convertible bonds as well as warrants and convertible bonds with the possibility of excluding subscription rights, (b) the creation of a new conditional capital Conditional Capital II and (c) on the amendment of § 7 (5) of the Articles of Association (share capital)

35,006,131 61.72 18,108,711 51.7301 16,897,420 48.2699 rejected

Contact details: Biofrontera AG, Hemmelrather Weg 201, D-51377 Leverkusen, Anke zur Mühlen, Phone: +49 (0) 214 87632 22, www.biofrontera.com

2

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Biofrontera AG published this content on 14 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 19:27:02 UTC.